Advertisement
Screener

ALIMERA SCIENCES, INC. Research and Development Expense (Excluding Acquired in Process Cost)

ALIMERA SCIENCES, INC. Research and Development Expense (Excluding Acquired in Process Cost)

ALIMERA SCIENCES, INC. reported Research and Development Expense (Excluding Acquired in Process Cost) of $4.61 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost · last filed 2023-03-31

  • ALIMERA SCIENCES, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2017-12-31 was $564.00K, a 6.42% increase year-over-year.
  • ALIMERA SCIENCES, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2017-09-30 was $3.30M, a 541.83% increase year-over-year.
  • ALIMERA SCIENCES, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2017-06-30 was $3.00K, a 99.45% decline year-over-year.
  • ALIMERA SCIENCES, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2017-03-31 was $350.00K, a 37.61% decline year-over-year.
  • ALIMERA SCIENCES, INC. research and development expense (excluding acquired in process cost) for fiscal 2021 was $4.61M, a 255.75% increase from fiscal 2020.
  • ALIMERA SCIENCES, INC. research and development expense (excluding acquired in process cost) for fiscal 2020 was $1.29M, a 251.90% increase from fiscal 2019.
  • ALIMERA SCIENCES, INC. research and development expense (excluding acquired in process cost) for fiscal 2019 was $368.00K, a 66.42% decline from fiscal 2018.
  • ALIMERA SCIENCES, INC. research and development expense (excluding acquired in process cost) for fiscal 2018 was $1.10M, a 74.00% decline from fiscal 2017.
Period endResearch and Development Expense (Excluding Acquired in Process Cost) 3 monthResearch and Development Expense (Excluding Acquired in Process Cost) 3 month as first filedResearch and Development Expense (Excluding Acquired in Process Cost) 6 monthResearch and Development Expense (Excluding Acquired in Process Cost) 6 month as first filedResearch and Development Expense (Excluding Acquired in Process Cost) 9 monthResearch and Development Expense (Excluding Acquired in Process Cost) 9 month as first filedResearch and Development Expense (Excluding Acquired in Process Cost) 12 monthResearch and Development Expense (Excluding Acquired in Process Cost) 12 month as first filed
2021-12-31$4.61M
10-K · filed 2023-03-31
2020-12-31$1.29M
10-K · filed 2022-03-23
2019-12-31$368.00K
10-K · filed 2021-03-05
2018-12-31$1.10M
10-K · filed 2020-03-02
2017-12-31$564.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25
$3.86M
derived: sum of 2 quarters · filed 2019-02-25
$3.87M
derived: sum of 3 quarters · filed 2019-02-25
$4.22M
10-K · filed 2019-02-25
2017-09-30$3.30M
10-Q · filed 2017-11-03
$3.30M
derived: sum of 2 quarters · filed 2017-11-03
$3.65M
10-Q · filed 2017-11-03
$4.18M
derived: sum of 4 quarters · filed 2018-03-02
2017-06-30$3.00K
10-Q · filed 2017-08-10
$354.00K
10-Q · filed 2017-08-10
$883.00K
derived: sum of 3 quarters · filed 2018-03-02
$1.40M
derived: sum of 4 quarters · filed 2018-03-02
2017-03-31$350.00K
10-Q · filed 2017-05-11
$880.00K
derived: sum of 2 quarters · filed 2018-03-02
$1.39M
derived: sum of 3 quarters · filed 2018-03-02
$1.94M
derived: sum of 4 quarters · filed 2018-03-02
2016-12-31$530.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02
$1.04M
derived: sum of 2 quarters · filed 2018-03-02
$1.58M
derived: sum of 3 quarters · filed 2018-03-02
$2.15M
10-K · filed 2018-03-02
2016-09-30$514.00K
10-Q · filed 2017-11-03
$1.57M
10-Q · filed 2016-11-04
$1.05M
derived: sum of 2 quarters · filed 2017-11-03
$1.62M
10-Q · filed 2017-11-03
$4.44M
10-Q · filed 2016-11-04
$2.05M
derived: sum of 4 quarters · filed 2017-11-03
2016-06-30$541.00K
10-Q · filed 2017-08-10
$1.46M
10-Q · filed 2016-08-05
$1.10M
10-Q · filed 2017-08-10
$2.87M
10-Q · filed 2016-08-05
$1.54M
derived: sum of 3 quarters · filed 2017-08-10
$2.48M
derived: sum of 4 quarters · filed 2017-08-10
2016-03-31$561.00K
10-Q · filed 2017-05-11
$1.57M
10-Q · filed 2016-05-06
$998.00K
derived: sum of 2 quarters · filed 2017-05-11
$1.94M
derived: sum of 3 quarters · filed 2017-05-11
$3.53M
derived: sum of 4 quarters · filed 2017-05-11
2015-12-31$437.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03
$1.38M
derived: sum of 2 quarters · filed 2017-03-03
$2.97M
derived: sum of 3 quarters · filed 2017-03-03
$2.40M
10-K · filed 2017-03-03
$2.75M
10-K · filed 2016-03-15
2015-09-30$940.00K
10-Q · filed 2016-11-04
$2.54M
derived: sum of 2 quarters · filed 2016-11-04
$1.96M
10-Q · filed 2016-11-04
$7.96M
derived: sum of 4 quarters · filed 2016-11-04
2015-06-30$1.59M
10-Q · filed 2016-08-05
$1.60M
10-Q · filed 2015-08-10
$2.90M
10-Q · filed 2016-08-05
$2.90M
10-Q · filed 2015-08-10
$7.01M
derived: sum of 3 quarters · filed 2016-08-05
$8.10M
derived: sum of 4 quarters · filed 2016-08-05
2015-03-31$1.31M
10-Q · filed 2016-05-06
$5.42M
derived: sum of 2 quarters · filed 2016-05-06
$6.50M
derived: sum of 3 quarters · filed 2016-05-06
$7.60M
derived: sum of 4 quarters · filed 2016-05-06
2014-12-31$4.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$5.20M
derived: sum of 2 quarters · filed 2016-03-15
$6.30M
derived: sum of 3 quarters · filed 2016-03-15
$7.59M
10-K · filed 2016-03-15
2014-09-30$1.08M
10-Q · filed 2015-11-09
$2.18M
derived: sum of 2 quarters · filed 2015-11-09
$3.48M
10-Q · filed 2015-11-09
2014-06-30$1.10M
10-Q · filed 2015-08-10
$2.40M
10-Q · filed 2015-08-10
2013-12-31$3.90M
10-K · filed 2016-03-15